Joel Cohen
Corporate Officer/Principal bij McGill University
Actieve functies van Joel Cohen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
McGill University | Corporate Officer/Principal | - | - |
Loopbaan van Joel Cohen
Eerdere bekende functies van Joel Cohen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MP Biomedicals Canada ULC
MP Biomedicals Canada ULC Miscellaneous Commercial ServicesCommercial Services MP Bio medicals Canada Ulc provides genomics and gene delivery research tools and services. The firm’s products include PCR, transfection, protemics, lab tools and instruments, and enzyme products. It has operations in Canada, France, Switzerland and the United States. The company was founded in 1991 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - | - |
AETERNA ZENTARIS INC. | Corporate Officer/Principal | - | - |
9342-8530 QUÉBEC INC. | Corporate Officer/Principal | - | - |
Bioniche, Inc. | Corporate Officer/Principal | - | - |
FENNEC PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
BELLUS HEALTH | Corporate Officer/Principal | - | - |
CANACCORD GENUITY GROUP INC. | Corporate Officer/Principal | - | - |
Opleiding van Joel Cohen
McGill University | Masters Business Admin |
Statistieken
Internationaal
Canada | 7 |
Verenigde Staten | 3 |
Operationeel
Corporate Officer/Principal | 8 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
CANACCORD GENUITY GROUP INC. | Finance |
FENNEC PHARMACEUTICALS INC. | Health Technology |
9342-8530 QUÉBEC INC. | Health Technology |
AETERNA ZENTARIS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
BELLUS Health, Inc.
BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Bioniche, Inc. | Health Technology |
MP Biomedicals Canada ULC
MP Biomedicals Canada ULC Miscellaneous Commercial ServicesCommercial Services MP Bio medicals Canada Ulc provides genomics and gene delivery research tools and services. The firm’s products include PCR, transfection, protemics, lab tools and instruments, and enzyme products. It has operations in Canada, France, Switzerland and the United States. The company was founded in 1991 and is headquartered in Montréal, Canada. | Commercial Services |
- Beurs
- Insiders
- Joel Cohen
- Ervaring